Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Scott Vizzi

Sports Medicine Largo, FL Medical Doctor

NPI 1396006482 CMS profile 63413

12416 66Th St Ste A, Largo, FL 33773

Open in the dashboard

General payments

$30,525

342 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Scott Vizzi of Largo, FL is reported in the CMS Open Payments database as having received $30,525 across 342 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 76th percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,867 41
2024 General $1,191 22
2023 General $3,811 49
2022 General $2,659 43
2021 General $5,506 62
2020 General $2,913 52
2019 General $9,577 73

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Scott Vizzi
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Scott Vizzi were reported at $4,867. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Scott Vizzi Sports Medicine median Middle half National median
2019 $9,577 $1,176 $199–$4,249 $163
2020 $2,913 $708 $96–$2,890 $114
2021 $5,506 $1,213 $152–$3,994 $132
2022 $2,659 $1,230 $159–$3,998 $149
2023 $3,811 $584 $146–$2,836 $160
2024 $1,191 $628 $163–$3,168 $164
2025 $4,867 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $13,599 179 payments
  2. Shoulder Innovations, Inc. $3,606 17 payments
  3. Arthrex, Inc. $3,581 18 payments
  4. Smith+Nephew, Inc. $2,805 28 payments
  5. MVP Orthopedics Inc $1,725 13 payments
  6. Encore Medical, LP $1,055 13 payments
  7. Medical Device Business Services, Inc. $964 9 payments
  8. Coastal Medical Technologies LLC $649 9 payments
  9. DePuy Synthes Sales Inc. $598 9 payments
  10. Zimmer Biomet Holdings, Inc. $431 4 payments
  11. Other $1,512 43 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $19,071 310 payments
  2. Travel and Lodging $6,885 28 payments
  3. Education $4,545 3 payments
  4. Gift $24 1 payment
Products named General payments · program years 2019–2025
  1. InSet System $3,606 17 payments
  2. MAKO Knees, Hips $2,393 16 payments
  3. MAKO Knees, Hips $1,187 11 payments
  4. TRIATHLON $1,102 14 payments
  5. REUNION $874 11 payments
  6. BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION $812 11 payments
  7. AEQUALIS PERFORM REVERSED $748 11 payments
  8. ACCOLADE Hips $744 16 payments
  9. Journey II BCS $713 6 payments
  10. ACCOLADE Hips $606 12 payments
  11. Other $14,322 225 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 11 drugs

Part D claims

500

Median for Orthopedic Surgery: 203

Drug cost

$3,428

Median for Orthopedic Surgery: $1,433

Branded share of claims

36.4%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 80 $980
Ondansetron Odt Ondansetron Brand 91 $840
Oxycodone Hcl Generic 54 $300
Ibuprofen Generic 20 $228
Cyclobenzaprine Hcl Generic 20 $208
Tramadol Hcl Generic 61 $186
Celecoxib Generic 14 $174
Meloxicam Generic 93 $172
Methylprednisolone Generic 23 $172
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 11 $115

The 10 drugs with the highest cost, of 11 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 57 billing codes

Paid by Medicare

$162,107

Of which drugs: $27,453

Medicare patients

267

Average age 73

Services billed

4,584

167 women, 100 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 69%
Ischemic heart disease 31%
Depression 29%
Diabetes 25%
Chronic kidney disease 25%
Osteoporosis 24%
Atrial fibrillation 17%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg J7322 Office 30 1,968 $26,547
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 159 1,202 $906

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

342 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record